Andrew Riso Kindeva Drug Delivery

Andrew Riso is currently the Commercial Lead, Intradermal Delivery for Kindeva Drug Delivery. He has more than a decade of business development, strategic planning, financing, market research and commercial analysis experience in the biotech and drug delivery space. Prior to joining Kindeva in 2022, he was the head of business development for a drug delivery biotech company focused on the development of a microneedle array patch technology. He has consulted for numerous biotech companies with a focus on strategic planning and capital formation. Andrew has a Bachelor of Arts from the University of Virginia, US.